While the study found no significant differences in the primary efficacy endpoint (time to first tolerated meal), the ipamorelin group showed reduced median time to first tolerated meal (25.3 hours versus 32.6 hours in placebo) and had fewer overall treatment-emergent adverse events (87.5% versus 94.8%)
These studies suggest potential BPC-157 benefits for digestive as well as joint and muscle integrity and functionality, laying the groundwork for further research in humans
There are no separate consult or membership fees
Seek Immediate Medical Attention If You Experience: Severe stomach pain that doesnt go away (could be a sign of pancreatitis) Pain in the upper right side of your belly, especially after meals (this could mean gallbladder issues) Signs of dehydration from extreme vomiting or diarrhea (such as dizziness, dry mouth, or dark urine) Swelling in your neck, trouble swallowing, or hoarseness (very rare, but possibly related to thyroid changes) Skin rashes, swelling of the face or lips, or trouble breathing (could be a sign of an allergic reaction) If you experience any of these, dont wait